(CTVA) Corteva - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US22052L1044
CTVA: Seeds, Herbicides, Insecticides, Fertilizers, Pesticides, Nitrogen
Corteva, Inc. stands as a pivotal player in the agriculture industry, operating through two core segments: Seed and Crop Protection. The Seed division is dedicated to advancing germplasm and traits that optimize crop yield, crucial for meeting global food demands. They offer trait technologies enhancing resistance to environmental stresses, diseases, and pests, alongside herbicide resistance. Additionally, they provide digital solutions to aid farmers in optimizing product selection and maximizing profitability, embedding technology to enhance agricultural efficiency.
The Crop Protection segment focuses on safeguarding crops from pests and diseases, and improving overall crop health. Their portfolio includes herbicides, insecticides, and nitrogen management solutions, essential for maintaining soil health and preventing nutrient loss. This segment underscores Cortevas commitment to sustainable agriculture, addressing critical challenges farmers face daily.
With operations spanning the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa, Cortevas global footprint is extensive. Incorporated in 2018 and headquartered in Indianapolis, Indiana, the company is strategically positioned to influence agricultural practices worldwide. Their website, corteva.com, offers deeper insights into their innovations and initiatives.
Financially, Corteva presents a robust profile with a market cap exceeding $42 billion USD. The current P/E ratio of 51.10 and forward P/E of 19.53 suggest investor confidence and anticipated growth. A P/S ratio of 2.57 indicates healthy revenue generation relative to its market value, while a P/B ratio of 1.80 reflects a reasonable valuation of its assets.
For investors and fund managers, Cortevas strategic focus on R&D and sustainability positions it well in a growing agriculture sector increasingly prioritizing technology and environmental stewardship. The companys emphasis on innovation and global reach makes it a compelling consideration for those seeking exposure to the agriculture industrys evolving landscape.
Additional Sources for CTVA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CTVA Stock Overview
Market Cap in USD | 41,517m |
Sector | Basic Materials |
Industry | Agricultural Inputs |
GiC Sub-Industry | Fertilizers & Agricultural Chemicals |
IPO / Inception | 2019-05-24 |
CTVA Stock Ratings
Growth 5y | 81.1% |
Fundamental | 10.6% |
Dividend | 58.6% |
Rel. Strength Industry | 12.4 |
Analysts | 4.26/5 |
Fair Price Momentum | 62.95 USD |
Fair Price DCF | 79.79 USD |
CTVA Dividends
Dividend Yield 12m | 1.14% |
Yield on Cost 5y | 3.09% |
Annual Growth 5y | 4.88% |
Payout Consistency | 100.0% |
CTVA Growth Ratios
Growth Correlation 3m | 60.5% |
Growth Correlation 12m | 73.8% |
Growth Correlation 5y | 74.5% |
CAGR 5y | 22.77% |
CAGR/Max DD 5y | 0.65 |
Sharpe Ratio 12m | -0.08 |
Alpha | 3.11 |
Beta | 0.56 |
Volatility | 26.68% |
Current Volume | 3614.2k |
Average Volume 20d | 3361.2k |
As of March 10, 2025, the stock is trading at USD 60.56 with a total of 3,614,203 shares traded.
Over the past week, the price has changed by +0.26%, over one month by -2.39%, over three months by +1.65% and over the past year by +11.19%.
Neither. Based on ValueRay Fundamental Analyses, Corteva is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 10.62 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CTVA as of March 2025 is 62.95. This means that CTVA is currently overvalued and has a potential downside of 3.95%.
Corteva has received a consensus analysts rating of 4.26. Therefor, it is recommend to buy CTVA.
- Strong Buy: 12
- Buy: 5
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CTVA Corteva will be worth about 70.5 in March 2026. The stock is currently trading at 60.56. This means that the stock has a potential upside of +16.48%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 69 | 14% |
Analysts Target Price | 66.4 | 9.6% |
ValueRay Target Price | 70.5 | 16.5% |